Mccook Dialysis Center is a medicare approved dialysis facility center in Mccook, Nebraska and it has 8 dialysis stations. It is located in Red Willow county at 801 West C St, Mccook, NE, 69001. You can reach out to the office of Mccook Dialysis Center at (308) 345-1916. This dialysis clinic is managed and/or owned by Davita. Mccook Dialysis Center has the following ownership type - Profit. It was first certified by medicare in July, 2002. The medicare id for this facility is 282517 and it accepts patients under medicare ESRD program.
| Name | Mccook Dialysis Center |
|---|---|
| Location | 801 West C St, Mccook, Nebraska |
| No. of Dialysis Stations | 8 |
| Medicare ID | 282517 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 801 West C St, Mccook, Nebraska, 69001 | |
| (308) 345-1916 | |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
| NPI Number | 1730141177 |
| Organization Name | Mccook Dialysis Center |
| Doing Business As | Renal Treatment Centers Illinois Inc |
| Address | 5200 Virginia Way Brentwood, Tennessee, 37027 |
| Phone Number | (615) 320-4214 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 10 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 19 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 157 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 8 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 52 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Mccook Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 26 |
| Hypercalcemia patient months | 211 |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 46 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 9 |
| Patients with Serumphosphor greater than 7 mg/dL | 3 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 22 |
| Patient months included in arterial venous fistula and catheter summaries | 132 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 51 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 16 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 28 |
| Hospitalization Rate in facility | 141.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 338.5 |
| Hospitalization Rate: Lower Confidence Limit | 63.6 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Mccook Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 17.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.9 |
| Readmission Rate: Lower Confidence Limit | 3.9 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Mccook Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.34 (As Expected) |
| SIR: Upper Confidence Limit | 4.43 |
| SIR: Lower Confidence Limit | .23 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Mccook Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 23 |
| Transfusion Rate in facility | 42 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 204 |
| Transfusion Rate: Lower Confidence Limit | 10.5 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Mccook Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 125 |
| Mortality Rate in facility | 19.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 29.4 |
| Mortality Rate: Lower Confidence Limit | 12.9 |
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago
News Archive
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
Rep. Frank Wolf (R-Va.) on Friday in a letter to President Obama said that the U.S. could lose its triple-A bond rating if Congress does not act quickly to overhaul U.S. entitlement programs, including Medicare and Medicaid, and reduce federal debt, the AP/Detroit News reports.
Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced that Bend Urology Associates has selected Aprima for its 10-provider practice located in Bend, Oregon.
› Verified 6 days ago